Role of perivascular adipose tissue on vascular reactive oxygen species in type 2 diabetes: A give-and-take relationship

Diabetes

Volumn 64, Issue 6, 2015, Pages 1904-1906

  Padilla, Jaume ^a,b   Vieira Potter, Victoria J ^a   Jia, Guanghong ^a,c   Sowers, James R ^a,b,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADIPOCYTE; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY WALL; ATHEROSCLEROSIS; BIOAVAILABILITY; BLOOD VESSEL; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; GENETIC VARIABILITY; HEART PROTECTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERNAL MAMMARY ARTERY; LYMPHOCYTIC INFILTRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; OXIDATIVE STRESS; PARACRINE SIGNALING; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; SMOOTH MUSCLE TONE; T LYMPHOCYTE; VASCULAR SMOOTH MUSCLE; WEIGHT GAIN; ARTERY; FEMALE; HUMAN; MALE; METABOLISM;

ADIPONECTIN; ADIPOSE TISSUE; ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; NADPH OXIDASE;

EID: 84940997273     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0096     Document Type: Note

References (23)

1. Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes 2014; 5:444-470
2. Guzik TJ, Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 2006; 11:524-533
3. Ihm S-H, Lee J-O, Kim S-J, et al. Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression. Atherosclerosis 2009; 206:47-53
4. Wendt MC, Daiber A, Kleschyov AL, et al. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med 2005; 39:381-391
5. Rask-Madsen C, King GL. Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 2007; 3:46-56
6. Vallejo S, Palacios E, Romacho T, Villalobos L, Peiró C, Sánchez-Ferrer CF. The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats. Cardiovasc Diabetol 2014; 13:158
7. Cannizzo B, Quesada I, Militello R, et al. Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression. Free Radic Res 2014; 48:526-533
8. Walker A, Kaplon R, Pierce G, Nowlan M, Seals D. Prevention of age-related endothelial dysfunction by habitual aerobic exercise in healthy humans: possible role of nuclear factor kB. Clin Sci (Lond) 2014; 127:645-654
9. Barry-Lane PA, Patterson C, van der Merwe M, et al. p47phox is required for atherosclerotic lesion progression in apoE(-/-) mice. J Clin Invest 2001; 108: 1513-1522
10. Judkins CP, Diep H, Broughton BRS, et al. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in apoE-/- mice. Am J Physiol Heart Circ Physiol 2010; 298:H24-H32
11. Brown NK, Zhou Z, Zhang J, et al. Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol 2014; 34:1621-1630
12. Payne GA, Kohr MC, Tune JD. Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. Br J Pharmacol 2012; 165:659-669
13. Omar A, Chatterjee TK, Tang Y, Hui DY, Weintraub NL. Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol 2014; 34: 1631-1636
14. Owen MK, Witzmann FA, McKenney ML, et al. Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation 2013; 128:9-18
15. Ishikawa Y, Ishii T, Asuwa N, Masuda S. Absence of atherosclerosis evolution in the coronary arterial segment covered by myocardial tissue in cholesterol-fed rabbits. Virchows Arch 1997; 430:163-171
16. Greif M, Becker A, von Ziegler F, et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29:781-786
17. Jeong JW, Jeong MH, Yun KH, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 71:536-539
18. Caselli C, D'Amico A, Cabiati M, Prescimone T, Del Ry S, Giannessi D. Back to the heart: the protective role of adiponectin. Pharmacol Res 2014; 82:9-20
19. Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C. Adiponectin: from obesity to cardiovascular disease. Obes Rev 2009; 10:269-279
20. Meijer RI, Bakker W, Alta C-LAF, et al. Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes 2013; 62:590-598
21. Lynch FM, Withers SB, Yao Z, et al. Perivascular adipose tissue-derived adiponectin activates BK(Ca) channels to induce anticontractile responses. Am J Physiol Heart Circ Physiol 2013; 304:H786-H795
22. Antonopoulos AS, Margaritis M, Coutinho P, et al. Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes 2015; 64:2207-2219
23. Youn J-Y, Siu KL, Lob HE, Itani H, Harrison DG, Cai H. Role of vascular oxidative stress in obesity and metabolic syndrome. Diabetes 2014; 63:2344-2355